AUTOLOGOUS HEAT SHOCK ROTEIN VACCINE FOR RECURRENT GLIOMA: UPDATED RESULTS OF A PHASE I CLINICAL TRIAL

被引：0
|
作者：
Parsa, Andrew [1 ]
Crane, Courtney [1 ]
Burkowski, Nicholas [1 ]
Cachola, Kristine [1 ]
Chang, Susan [1 ]
Fedoroff, Anne
Kivette, Valerie
Mcdermott, Michael [1 ]
Murray, Joseph [1 ]
Page, Margaretta [1 ]
Prados, Michael [1 ]
Rabbitt, Jane [1 ]
Berger, Mitchel [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [21] Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
    Ge, Chunlei
    Li, Ruilei
    Song, Haifeng
    Geng, Tao
    Yang, Jinyan
    Tan, Qinghua
    Song, Linfeng
    Wang, Ying
    Xue, Yuanbo
    Li, Zhen
    Dong, Suwei
    Zhang, Zhiwei
    Zhang, Na
    Guo, Jiyin
    Hua, Lin
    Chen, Siyi
    Song, Xin
    BMC CANCER, 2017, 17
  • [22] Cytomegalovirus vaccine: phase II clinical trial results
    Rieder, F.
    Steininger, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 95 - 102
  • [23] Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
    Phuphanich, Surasak
    Supko, Jeffrey G.
    Carson, Kathryn A.
    Grossman, Stuart A.
    Nabors, L. Burt
    Mikkelsen, Tom
    Lesser, Glenn
    Rosenfeld, Steve
    Desideri, Serena
    Olson, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (01) : 95 - 103
  • [24] Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM).
    Lassman, Andrew B.
    Reardon, David A.
    Lee, Eudocia Quant
    Iwamoto, Fabio Massaiti
    Diaz-Mitoma, Francisco
    Anderson, David E.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
    Surasak Phuphanich
    Jeffrey G. Supko
    Kathryn A. Carson
    Stuart A. Grossman
    L. Burt Nabors
    Tom Mikkelsen
    Glenn Lesser
    Steve Rosenfeld
    Serena Desideri
    Jeffrey J. Olson
    Journal of Neuro-Oncology, 2010, 100 : 95 - 103
  • [26] INTERIM RESULTS OF THE EXTENSION PHASE OF A PHASE I/IIA TRIAL OF A THERAPEUTIC CMV VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM)
    Wen, Patrick
    Reardon, David
    Lee, Eudocia
    Iwamoto, Fabio
    Anderson, David
    Diaz-Mitoma, Francisco
    Lassman, Andrew
    NEURO-ONCOLOGY, 2019, 21 : 7 - 7
  • [27] A phase II study of anlotinib in the treatment of recurrent high-grade glioma: Updated results
    Dai, H.
    Zhang, M.
    Zhao, S.
    Zhang, Q.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S676 - S677
  • [28] PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
    Thompson, Eric
    Landi, Daniel
    Thompson, Eric
    Lipp, Eric
    Balajonda, Bea
    Herndon, James, II
    Buckley, Evan
    Flahiff, Charlene
    Jaggers, Denise
    Schroeder, Kristin
    Randazzo, Dina
    Desjardins, Annick
    Johnson, Maggie
    Peters, Katherine
    Khasraw, Mustafa
    Malinzak, Michael
    Mitchell, Duane
    Ashley, David
    Sampson, John
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [29] Vaginal mucosal vaccine for recurrent urinary tract infections in women: Results of a phase 2 clinical trial
    Hopkins, Walter J.
    Elkahwaji, Johny
    Beierle, Lori M.
    Leverson, Glen E.
    Uehling, David T.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 1349 - 1353
  • [30] HEMATOPOIETIC STEM CELL GENE THERAPY FOR CYSTINOSIS (PHASE I/II CLINICAL TRIAL): UPDATED RESULTS
    Barshop, Bruce A.
    Ball, Edward
    Dohil, Magdalene
    Dohil, Ranjan
    Fiorini, Claudia
    Biasco, Luca
    Kohn, Donald
    Afshari, Natalie
    Cherqui, Stephanie
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 249 - 249
12345